Lignan from

Hyejin Lee, Ji Hye Jeong, Jae-Ha Ryu

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

0.8field-weighted citation impact, top 29% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

Exploring the medicinal potential of Alnus japonica: a comprehensive review of phytochemicals and therapeutic applications.Naunyn-Schmiedeberg's archives of pharmacology · 2026
Review
The PPIase Activity of CypB Is Essential for the Activation of Both AKT/mTOR and XBP1s Signaling Pathways during the Differentiation of 3T3-L1 Preadipocytes.Nutrients · 2024
Article
Insights on Dietary Polyphenols as Agents against Metabolic Disorders: Obesity as a Target Disease.Antioxidants (Basel, Switzerland) · 2023
Review
Stages of preadipocyte differentiation: biomarkers and pathways for extracellular structural remodeling.Hereditas · 2022
Article
Comparison of the Chemical Components, Efficacy and Mechanisms of Action ofInternational journal of molecular sciences · 2022
Article
A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1.Scientific reports · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hyejin LeeResearch Institute of Pharmaceutical Sciences and College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea.

Ji Hye JeongResearch Institute of Pharmaceutical Sciences and College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea.

Jae-Ha RyuResearch Institute of Pharmaceutical Sciences and College of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea.ORCID 0000-0002-6726-2297

Sookmyung Women's University · KR

Funding

National Research Foundation of Korea NRF-2018R1D1A1B07049941Sookmyung Women's University Specialization Program Funding SP1-201809-6

6 · The paper itself

Abstract

In the present study, we isolated a lignan ((-)-(2

Indexed as

Up-Regulation3T3-L1 CellsAdipogenesisAlnusAnimalsCell CycleCell DifferentiationDose-Response Relationship, DrugForkhead Box Protein O1Gene Expression RegulationLignansLipid MetabolismMicePhosphorylationProto-Oncogene Proteins c-aktForkhead Box Protein O1Foxo1 protein, mouseLignansProto-Oncogene Proteins c-akt3T3-L1adipogenesisAlnus japonicaFOXO1lignan

Identifiers

PMID32717959

DOI10.3390/molecules25153346

PMCPMC7435632

OpenAlexW3045466534

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.